Safety Center

Verify your GLP-1 provider before you enroll

GLP-1 medications are prescription drugs with real side effects and a complex regulatory landscape. Over 50 FDA warning letters have been issued to GLP-1 compounding pharmacies since 2025. Verify your provider, understand side effects, and know your rights before starting treatment.

Independent safety resources. No provider pays for placement in our safety assessments.

Safety Resource

Side Effects Guide (cross-drug)

Comprehensive breakdown of GLP-1 side effects with exact percentages from FDA prescribing information. Covers nausea, GI issues, rare complications, and how to manage them.

44%experience nausea
Open Resource
Safety Resource

Wegovy side effects deep dive

Per-drug guide: rates from the FDA-approved Wegovy label, week-by-week timeline, management protocols for nausea/diarrhea/constipation, red-flag symptoms, and the boxed warning explained.

44%Wegovy nausea rate
Open Resource
Safety Resource

Zepbound side effects deep dive

Per-drug guide for tirzepatide: rates from the FDA-approved Zepbound label, the 24-week dose-escalation timeline, management protocols including hair shedding (2× Wegovy's rate), and the boxed warning.

33%Zepbound nausea rate
Open Resource
Safety Resource

Ozempic side effects deep dive

Per-drug guide for the FDA-approved diabetes doses (0.5mg / 1mg / 2mg). Includes the Ozempic-specific diabetic-retinopathy warning, hypoglycemia management when combined with insulin or sulfonylureas, and the boxed warning.

20.3%Ozempic 1mg nausea rate
Open Resource
Safety Resource

Foundayo side effects deep dive

Per-drug guide for orforglipron — Eli Lilly's first oral GLP-1, FDA-approved April 2026. No fasting required. Trial data from ATTAIN-1, $149/mo self-pay, 12.4% weight loss profile.

35%Foundayo nausea rate
Open Resource
Safety Resource

Mounjaro side effects deep dive

Per-drug guide for tirzepatide at the diabetes indication (5mg / 10mg / 15mg). Same molecule as Zepbound but FDA-approved for T2DM. Includes diabetic-retinopathy warning, hypoglycemia management.

21%Mounjaro 15mg nausea rate
Open Resource
Safety Resource

Rybelsus side effects deep dive

Per-drug guide for oral semaglutide (7mg / 14mg). FDA-approved for type 2 diabetes. Covers the unique fasting protocol (4oz water, 30min fast — non-negotiable for absorption), management protocols, and red flags.

20%Rybelsus 14mg nausea rate
Open Resource
Safety Resource

FDA Warning Letters & Alerts

Track FDA enforcement actions against GLP-1 compounding pharmacies and telehealth providers. 50+ warning letters issued since 2025.

50+FDA warnings issued
Open Resource
Safety Resource

Provider Safety Checker

Verify any GLP-1 provider's FDA compliance, pharmacy licensing, and trust score. Search 32 verified providers and 17 FDA-warned companies.

49providers tracked
Open Resource
Safety Resource

GLP-1 Lawsuit Tracker

Monitor active litigation against GLP-1 manufacturers and providers. Class actions, individual claims, and regulatory enforcement updates.

$6B+in active lawsuits
Open Resource
Essential Safety Tips

Three things to do before you start

1

Verify Your Provider

Use our Safety Checker to confirm FDA compliance, pharmacy licensing, and trust scores before enrolling.

2

Start Low, Go Slow

Follow the prescribed titration schedule. Rushing to higher doses increases GI side effects. Use our dosing timeline tool.

3

Report Problems

Report adverse reactions to FDA MedWatch and your prescribing provider immediately.

Top Picks

Four programs our readers click through most.

Embody

7.3/10
$299/mo·Compounded

Gala

7.2/10
$149/mo·Brand & Compounded

Sesame Care

7.9/10
$99/mo·Brand & Compounded

Affiliate links — we earn a commission at no extra cost to you. Selection reflects what readers convert through, not editorial endorsement. Full ranking + methodology at glp1picks.com.